ASCO Guidelines

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update

White Blood Cell Growth Factors Guideline Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 1

Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1

Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline

Management of Cancer During Pregnancy Guideline

Management of Antineoplastic Extravasation: ONS-ASCO Guideline

Postmastectomy Radiation Therapy: ASTRO-ASCO-SSO Guideline

Geriatric Assessment Global Guideline

Oncology Medical Homes: ASCO-COA Standards Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2025.1 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2025.1 Part 1

Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards Update

Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Guideline

Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Guideline Update

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Rapid Update

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Guideline Update

Fertility Preservation in People with Cancer Guideline Update

Opioid Conversion in Adults with Cancer: MASCC-ASCO-AAHPM-HPNA-NICSO Guideline

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2024.3 Part 1

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.3 Part 2

TORS in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma Guideline

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer Guideline Update

Germline and Somatic Genomic Testing for Metastatic Prostate Cancer Guideline

Treatment of Pleural Mesothelioma Update

Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline

Systemic Therapy for SCLC Rapid Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.2

Management of Locally Advanced Rectal Cancer Guideline

Management of Stage III NSCLC Rapid Update

Selection of Germline Genetic Testing Panels in Patients with Cancer Guideline

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.1

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors Rapid Update

Management of Fatigue in Adult Survivors of Cancer: ASCO-SIO Guideline Update

Palliative Care for Patients with Cancer Guideline Update

Prevention and Management of Osteoradionecrosis in Patients with Head and Neck Cancer Treated with Radiation Therapy: ISOO-MASCC-ASCO Guideline

Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations

Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline Update

Vaccination of Adults with Cancer Guideline

Cannabis and Cannabinoids in Adults with Cancer Guideline

Endocrine and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer – Capivasertib-Fulvestrant: Rapid Guideline Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.3 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.3 Part 1

Systemic Treatment of Patients with Metastatic Breast Cancer Resource-Stratified Guideline

Germline Testing in Patients with Breast Cancer: ASCO-SSO Guideline

Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update

Systemic Therapy for SCLC: ASCO-OH (CCO) Guideline

Management of Metastatic Renal Clear Cell Cancer Rapid Recommendation Update